Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325

Benzinga Newsdesk www.benzinga.com Neutral 50.8%

Neg 0% Neu 50.8% Pos 0%

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $315 to $325.